Citi Downgrades Abbott Labs (ABT) to Sell

Citi analyst Amit Hazan downgraded Abbott Labs (NYSE: ABT) from Neutral to Sell with a price target of $68.00 (from $72.00).

For an analyst ratings summary and ratings history on Abbott Labs click here. For more ratings news on Abbott Labs click here.

Shares of Abbott Labs closed at $72.33 yesterday.

You May Also Be Interested In

• Piper Sandler: PFA survey is most positive for Medtronic, Inc. (MDT)
• Gartner (IT) PT Lowered to $206 at BMO Capital, adjusting estimates
• Pony AI Inc (PONY) PT Lowered to $17 at BofA Securities